Literature DB >> 18003693

Commentary on NICE guidelines for alteplase for the treatment of acute ischaemic stroke.

R I Lindley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18003693      PMCID： PMC2095744          DOI： 10.1136/hrt.2007.128835

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

Review 1.  Thrombolytic therapy in acute stroke: neurologists, get off your hands!

Authors:  S H Horowitz
Journal:  Arch Neurol       Date:  1998-02

2.  Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

Authors:  J C Grotta; W S Burgin; A El-Mitwalli; M Long; M Campbell; L B Morgenstern; M Malkoff; A V Alexandrov
Journal:  Arch Neurol       Date:  2001-12

3.  Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project.

Authors:  Lewis B Morgenstern; Lara Staub; Wenyaw Chan; Theodore H Wein; L Kay Bartholomew; Mary King; Robert A Felberg; W Scott Burgin; Janet Groff; Susan L Hickenbottom; Kamaldeen Saldin; Andrew M Demchuk; Anjali Kalra; Anupma Dhingra; James C Grotta
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

5.  Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction.

Authors:  D Ketley; K L Woods
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

6.  Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life.

Authors:  Joanna M Wardlaw; Janelle Seymour; John Cairns; Sarah Keir; Steff Lewis; Peter Sandercock
Journal:  Stroke       Date:  2004-09-30       Impact factor: 7.914

7.  Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.

Authors:  Timothy John Ingall; William Michael O'Fallon; Kjell Asplund; Lewis Robert Goldfrank; Vicki S Hertzberg; Thomas Arthur Louis; Teresa J Hengy Christianson
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

8.  Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test.

Authors:  Joseph Harbison; Omar Hossain; Damian Jenkinson; John Davis; Stephen J Louw; Gary A Ford
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

Review 9.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

10.  Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study.

Authors:  Joanna M Wardlaw; Andrew J Farrall; David Perry; Rudiger von Kummer; Orell Mielke; Thierry Moulin; Alfonso Ciccone; Michael Hill
Journal:  Stroke       Date:  2007-03-08       Impact factor: 7.914
View more
  2 in total

1.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Thrombolytic therapy for acute ischemic stroke beyond three hours.

Authors:  Christopher R Carpenter; Samuel M Keim; William Kenneth Milne; William J Meurer; William G Barsan
Journal:  J Emerg Med       Date:  2010-06-25       Impact factor: 1.484
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.